Multiple Myeloma Awareness Month: When the Doctor Becomes the Caregiver

Read More

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Reinke S., et al.
November 2020
Authors and Affiliates
Sarah Reinke 1, Paul J Bröckelmann 2, Ingram Iaccarino 1, Maria Alejandra Garcia-Marquez 2, Sven Borchmann 3, Franziska Jochims 4, Michaela Kotrova 5, Karol Pal 6, Monika Brüggemann 5, Elena Hartmann 7, Stephanie Sasse 8, Carsten Kobe 9, Stephan Mathas 10, Martin Soekler 11, Ulrich Keller 12, Matthias Bormann 13, Andreas Zimmermann 14, Julia Richter 15, Michael Fuchs 3, Bastian von Tresckow 16, Peter Borchmann 17, Hans Schlößer 18, Michael von Bergwelt-Baildon 19, Andreas Rosenwald 20, Andreas Engert 21, Wolfram Klapper 22; 1 University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. 2 University Hospital of Cologne, Cologne, Germany. 3 University of Cologne, Cologne, Germany. 4 University Hospital Schleswig-Holstein, Campus Kiel, Groß Grönau, Germany. 5 Universitätsklinikum Schleswig-Holstein, Kiel, Germany. 6 University Hospital Schleswig-Holstein, Kiel, Germany. 7 University of Würzburg, Würzburg, Germany. 8 Cologne, Germany. 9 Department of Nuclear Medicine, University of Cologne, Cologne, Germany, Cologne, Germany. 10 Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. 11 Hospital Thun, Thun, Switzerland. 12 Charite - Universitätsmedizin Berlin, Berlin, Germany. 13 Klinikum Bremen-Mitte, Bremen, Germany. 14 University Hospital LMU Munich, Munich, Germany. 15 Christian-Albrechts University Kiel, Kiel, Germany. 16 University Hospital Essen, Germany. 17 Uniklinik Koeln, Koeln, Germany. 18 University Hospital of Cologne. 19 University Hospital LMU, Munich, Germany. 20 University of Wuerzburg, Wuerzburg, Germany. 21 University Hospital of Cologne, Koeln, Germany. 22 Department of Pathology, Kiel, Kiel, Germany.